M R Taskinen

Author PubWeight™ 213.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 14.03
2 Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005 13.18
3 Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999 2.36
4 Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 1996 2.33
5 Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 2000 1.90
6 Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group. Circulation 1997 1.89
7 Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care 2000 1.76
8 Serum complement and familial combined hyperlipidemia. Atherosclerosis 1997 1.64
9 Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet 1998 1.52
10 The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 2001 1.51
11 Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 1997 1.49
12 Lipid intolerance in smokers. J Intern Med 1995 1.48
13 Effect of muscular exercise on insulin secretion. Diabetes 1968 1.48
14 Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 2002 1.43
15 Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007 1.34
16 Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988 1.32
17 Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 2011 1.32
18 Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest 1997 1.30
19 Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 1997 1.27
20 Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet 1999 1.21
21 Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis 1996 1.20
22 Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 1991 1.20
23 Lipoprotein lipase in diabetes. Diabetes Metab Rev 1987 1.19
24 Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins. Metabolism 1978 1.18
25 Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 1997 1.17
26 Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996 1.17
27 Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes. Scand Cardiovasc J 2001 1.16
28 Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996 1.16
29 Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis 1999 1.16
30 Metabolic effects of metformin in patients with impaired glucose tolerance. Diabet Med 2001 1.15
31 Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res 1989 1.13
32 Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes 1998 1.11
33 Alcohol-induced changes in serum lipoproteins and in their metabolism. Am Heart J 1987 1.10
34 Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation 2000 1.10
35 Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes 1988 1.10
36 Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Relation to high-density and very-low-density lipoproteins and response to treatment. Diabetologia 1979 1.09
37 Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 1997 1.07
38 The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997 1.07
39 The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 1994 1.07
40 Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Ann Intern Med 1999 1.05
41 Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy. J Clin Invest 1985 1.05
42 Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost 2001 1.05
43 Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man. Atherosclerosis 1978 1.03
44 Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care 1999 1.02
45 Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group. J Lipid Res 1996 0.98
46 Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991 0.98
47 Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000 0.98
48 Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 1999 0.97
49 Quantitative comparison of angiographic characteristics of coronary artery disease in patients with noninsulin-dependent diabetes mellitus compared with matched nondiabetic control subjects. Am J Cardiol 1997 0.97
50 Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism. Diabetes 1999 0.96
51 Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989 0.96
52 A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression. J Lipid Res 1996 0.96
53 Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma insulin. Diabetes 1968 0.96
54 The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis 1998 0.95
55 Endothelial dysfunction in men with small LDL particles. Circulation 2000 0.94
56 High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man--evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase. Clin Chim Acta 1981 0.93
57 Insulin resistance is a prominent feature of patients with pancreatogenic diabetes. Metabolism 1986 0.92
58 High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metabolism 1982 0.92
59 Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus. Am J Cardiol 2000 0.92
60 Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol. J Lipid Res 1997 0.92
61 Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes 1986 0.91
62 Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal men. Metabolism 1989 0.91
63 Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism. Am Heart J 1987 0.91
64 Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia 1996 0.91
65 HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus. Circulation 1995 0.91
66 Lipoprotein lipase of adipose tissue and skeletal muscle in human obesity: response to glucose and to semistarvation. Metabolism 1981 0.91
67 Lipoprotein lipase activity in adipose tissue and in postheparin plasma in human obesity. Acta Med Scand 1977 0.91
68 Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab 1983 0.91
69 Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes 1996 0.91
70 Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 1995 0.91
71 Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. J Clin Invest 1998 0.90
72 Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care 2001 0.90
73 Acute effects of ethanol and acetate on glucose kinetics in normal subjects. Am J Physiol 1988 0.90
74 Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes 1993 0.90
75 Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus. Diabetologia 2007 0.90
76 No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families. Arterioscler Thromb Vasc Biol 1997 0.89
77 Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment. Atherosclerosis 2001 0.89
78 High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 1995 0.88
79 Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism. J Clin Endocrinol Metab 1993 0.88
80 Phenotype expression in familial combined hyperlipidemia. Atherosclerosis 1997 0.88
81 Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM. Am J Physiol 1989 0.87
82 Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer. J Clin Oncol 1996 0.87
83 Effects of caloric restriction on lipid metabolism in man: changes of tissue lipoprotein lipase activities and of serum lipoproteins. Atherosclerosis 1979 0.87
84 Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy. Diabetes 1986 0.87
85 Early response of plasma insulin to small doses of intravenous glucose: effect of obesity. J Clin Endocrinol Metab 1974 0.87
86 Postheparin plasma lipoprotein and hepatic lipases in preterm neonates. Pediatr Res 1984 0.86
87 Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects. Coron Artery Dis 2001 0.86
88 Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid. Acta Med Scand 1969 0.86
89 Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997 0.86
90 Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group. Diabetologia 1995 0.85
91 Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. J Clin Endocrinol Metab 1984 0.85
92 Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet 1991 0.85
93 Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity. Diabetes Care 1994 0.85
94 Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease. Eur J Clin Invest 2006 0.85
95 Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 1987 0.85
96 Metabolic effects of liver transplantation in cirrhotic patients. J Clin Invest 1997 0.85
97 Coronary flow reserve in young men with familial combined hyperlipidemia. Circulation 1999 0.85
98 Prevalence of familial hypercholesterolemia among young north Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction. J Lipid Res 1993 0.85
99 Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 1994 0.84
100 Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer. J Clin Endocrinol Metab 1996 0.84
101 XbaI and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland. Atherosclerosis 1988 0.84
102 G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2000 0.84
103 Ethanol-induced alterations of glucose tolerance, postglucose hypoglycemia, and insulin secretion in normal, obese, and diabetic subjects. Diabetes 1975 0.84
104 Postprandial lipid metabolism in diabetes. Atherosclerosis 1998 0.84
105 Sequence of alcohol-induced initial changes in plasma lipoproteins (VLDL and HDL) and lipolytic enzymes in humans. Metabolism 1985 0.84
106 Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab 1988 0.84
107 Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity. Diabetologia 1982 0.83
108 Changes of high density lipoprotein subfraction concentration and composition by intralipid in vivo and by lipolysis of intralipid in vitro. Arteriosclerosis 1984 0.83
109 Effects of endogenous sex steroids on serum lipoproteins and postheparin plasma lipolytic enzymes. J Clin Endocrinol Metab 1988 0.83
110 The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a). Metabolism 1991 0.83
111 Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke. Arterioscler Thromb Vasc Biol 1997 0.83
112 Hyperlipidaemia in diabetes. Baillieres Clin Endocrinol Metab 1990 0.83
113 Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. Atherosclerosis 1997 0.83
114 Effect of acute vigorous exercise on lipoprotein lipase activity of adipose tissue and skeletal muscle in physically active men. Artery 1980 0.83
115 Effect of parenteral hyperalimentation on serum lipoproteins and on lipoprotein lipase activity of adipose tissue and skeletal muscle. Eur J Clin Invest 1981 0.83
116 ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency. Arterioscler Thromb Vasc Biol 1995 0.82
117 A proposal to redefine familial combined hyperlipidaemia -- third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation. Eur J Clin Invest 2002 0.82
118 Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group. Eur J Clin Invest 1998 0.82
119 Characterization of lipase activities in obese Pima indians. Decreases with weight reduction. J Clin Invest 1982 0.82
120 Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man. Diabetologia 1984 0.82
121 A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of human adipose tissue and skeletal muscle. Clin Chim Acta 1980 0.82
122 Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus. Metabolism 1991 0.82
123 Glycemic control and serum lipoproteins after total pancreatectomy. Ann Clin Res 1985 0.82
124 Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects. Atherosclerosis 1999 0.81
125 Does familial hypertriglyceridemia predispose to NIDDM? Diabetes Care 1993 0.81
126 Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. Atherosclerosis 1988 0.81
127 Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities. J Lipid Res 1998 0.81
128 Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects of obesity and non-insulin-dependent diabetes mellitus. Am Heart J 1987 0.81
129 A marathon run increases the susceptibility of LDL to oxidation in vitro and modifies plasma antioxidants. Am J Physiol 1999 0.81
130 Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia. Nutr Metab Cardiovasc Dis 2004 0.81
131 High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity. Atherosclerosis 1986 0.81
132 Glucose tolerance, plasma lipoproteins and tissue lipoprotein lipase activities in body builders. Eur J Appl Physiol Occup Physiol 1984 0.81
133 Asymptomatic coronary artery disease in diabetes: relation to common risk factors, lipoproteins, apoproteins and apo E polymorphism. Acta Diabetol 1994 0.80
134 Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy. Arteriosclerosis 1990 0.80
135 High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawal. Eur J Clin Invest 1993 0.80
136 Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis 1997 0.80
137 Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2001 0.80
138 Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J Lipid Res 1996 0.80
139 Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis. J Lipid Res 2004 0.80
140 Postheparin plasma lipoprotein and hepatic lipase activities in hyperinsulinemic infants of diabetic mothers and in large-for-date infants at birth. Pediatr Res 1986 0.80
141 Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1998 0.79
142 Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus. Diabet Med 2000 0.79
143 Serum lipids and lipoproteins in insulin-dependent diabetic subjects during high-carbohydrate, high-fiber diet. Diabetes Care 1983 0.79
144 In vitro catabolism of human plasma very low density lipoproteins. Effects of VLDL concentration on the interconversion of high density lipoprotein subfractions. Atherosclerosis 1982 0.79
145 Post-heparin plasma lipoprotein and hepatic lipases. Relationships to high density lipoprotein cholesterol and to apolipoprotein CII in familial hyperalphalipoproteinemic and in normal subjects. Atherosclerosis 1980 0.79
146 A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men. Growth Horm IGF Res 2000 0.79
147 Increased volume of gastric contents in diabetic patients undergoing renal transplantation: lack of effect with cisapride. Acta Anaesthesiol Scand 1992 0.79
148 Apolipoprotein CII in type I hyperlipoproteinemia. A study in three cases. J Lab Clin Med 1980 0.79
149 Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993 0.79
150 Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant. J Lipid Res 1999 0.79
151 Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol. Circulation 1998 0.79
152 Dansyl phosphatidylethanolamine-labeled very low density lipoproteins. A fluorescent probe for monitoring lipolysis. J Biol Chem 1980 0.79
153 Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII). Arterioscler Thromb Vasc Biol 1997 0.79
154 The insulin secretion rate in obesity. Postgrad Med J 1971 0.79
155 Relation between H.D.L.-cholesterol levels and triglyceride metabolism. Lancet 1978 0.78
156 Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states. Atherosclerosis 1998 0.78
157 Lack of sex differences in high density lipoproteins in Pima Indians. Studies of obesity, lipase activities, and steroid hormones. Arteriosclerosis 1987 0.78
158 Aggregation of dimyristoylphosphatidylglycerol liposomes by human plasma low density lipoprotein. Biochim Biophys Acta 1998 0.78
159 Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease. Metabolism 1994 0.78
160 Effect of diphenylhydantoin on plasma-insulin in insulinoma. Lancet 1973 0.78
161 Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease. J Lipid Res 1992 0.78
162 Comparison of the effects of two different doses of alcohol on serum lipoproteins, HDL-subfractions and apolipoproteins A-I and A-II: a controlled study. Eur J Clin Invest 1988 0.78
163 Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity. Atherosclerosis 1993 0.78
164 Role of apolipoproteins E and C in type V hyperlipoproteinemia. J Lipid Res 1988 0.78
165 Acquired liver fat is a key determinant of serum lipid alterations in healthy monozygotic twins. Obesity (Silver Spring) 2013 0.78
166 Postheparin plasma lipase activities and plasma lipoproteins in newborn infants. Pediatr Res 1984 0.78
167 Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families. Atherosclerosis 2000 0.78
168 Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler Thromb 1992 0.78
169 Effects of dietary cholesterol on plasma lipoproteins and their subclasses in IDDM patients. Diabetologia 1998 0.78
170 LDL subclasses in IDDM patients: relation to diabetic nephropathy. Diabetologia 1994 0.78
171 In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. J Am Coll Cardiol 1997 0.78
172 Comparison of acute daytime and nocturnal insulinization on diurnal glucose homeostasis in NIDDM. Diabetes Care 1994 0.77
173 Changes in biological activity and immunoreactive mass of lipoprotein lipase in congenital nephrosis: relationship to hypertriglyceridaemia. Eur J Clin Invest 1993 0.77
174 New insights into the regulation of lipoprotein metabolism: studies in procaryocytes, eukaryocytes, rodents, pigs, and people. Curr Opin Lipidol 1997 0.77
175 Role of hepatic endothelial lipase in the metabolism of plasma HDL. Atherosclerosis 1982 0.77
176 In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency. Atherosclerosis 1997 0.77
177 Regulation of apolipoprotein A-I-containing lipoproteins in IDDM. Diabetes 1993 0.77
178 Suppression of nocturnal fatty acid concentrations by bedtime carbohydrate supplement in type 2 diabetes: effects on insulin sensitivity, lipids, and glycemic control. Am J Clin Nutr 2000 0.77
179 Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia. Metabolism 1995 0.77
180 Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy. Thromb Haemost 2000 0.77
181 Nocturnal hypertriglyceridemia and hyperinsulinemia following moderate evening intake of alcohol. Acta Med Scand 1977 0.77
182 Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients. J Intern Med 1995 0.77
183 The 16th annual meeting of the European Lipoprotein Club. Arterioscler Thromb 1994 0.77
184 A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial. Control Clin Trials 1997 0.77
185 Comparison of three fatty meals in healthy normolipidaemic men: high post-prandial retinyl ester response to soybean oil. Eur J Clin Invest 1998 0.77
186 The Asn-291-->Ser and Ser-477-->Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia. Eur J Clin Invest 1997 0.77
187 Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes. Diabet Med 1993 0.77
188 Enzymes involved in triglyceride hydrolysis. Baillieres Clin Endocrinol Metab 1987 0.77
189 Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients. Diabetes 1996 0.77
190 LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes. Atherosclerosis 1995 0.77
191 Lipoprotein(a) in type 1 diabetic patients with renal disease. Diabet Med 1994 0.77
192 Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy. Diabetes Care 1994 0.77
193 Growth, serum lipoproteins and apoproteins in infants with congenital nephrosis. Clin Nephrol 1992 0.77
194 Catabolism of human very low density lipoproteins in vitro: a fluorescent phospholipid method for monitoring lipolysis. J Lipid Res 1981 0.76
195 Lipoprotein lipase activity in adipose tissue and skeletal muscle of human diabetics during insulin deprivation and restoration. Scand J Clin Lab Invest 1981 0.76
196 A novel amino acid substitution (His183-->Gln) in exon 5 of the lipoprotein lipase gene results in loss of catalytic activity: phenotypic expression of the mutant gene in a heterozygous state. J Lipid Res 1994 0.76
197 Effect of sulfonylurea therapy on plasma lipids and high-density lipoprotein composition in non-insulin-dependent diabetes mellitus. Am J Med 1985 0.76
198 Basal and postprandial lipoprotein lipase activity in adipose tissue during caloric restriction and refeeding. Metabolism 1987 0.76
199 Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a). J Clin Endocrinol Metab 1999 0.76
200 Lipoprotein lipase activity of adipose tissue, skeletal muscle and post-heparin plasma in primary endogenous hypertriglyceridaemia: relation to lipoprotein pattern and to obesity. Eur J Clin Invest 1982 0.76
201 Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report. Atherosclerosis 1994 0.76
202 On the mechanism of the lipoprotein lipase-induced fluorescence changes in dansyl phosphatidylethanolamine-labeled very low density lipoproteins. J Biol Chem 1980 0.76
203 Human postheparin plasma hepatic lipase activity against triacylglycerol and phospholipid substrates. Clin Chim Acta 1982 0.76
204 Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes. Diabetes Care 1993 0.76
205 Effect of insulin treatment on fatty acids of plasma and erythrocyte membrane lipids in type 2 diabetes. Clin Chim Acta 1988 0.76
206 Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 1993 0.76
207 Response letter to D. Singh-franco et al. Diabetes Obes Metab 2012 0.75
208 [Glucagon and diabetes]. Duodecim 1976 0.75
209 Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens. Atherosclerosis 1996 0.75
210 [The significance of the determination of serum insulin]. Duodecim 1968 0.75
211 C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy. Ann Clin Res 1984 0.75
212 Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients. Diabetologia 2000 0.75
213 The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients. Acta Diabetol 1994 0.75
214 Glucose tolerance, plasma insulin and lipids in postmenopausal women during sequential oestrogen-progestin treatment. Acta Obstet Gynecol Scand Suppl 1971 0.75
215 Insulin deficiency associated with hypoglycemia and good glucose tolerance in hypopituitarism. Report of a case with acromegaly developing pituitary apoplexy. Acta Med Scand 1974 0.75
216 [Low serum HDL-cholesterol level in a young body-builder]. Duodecim 1992 0.75
217 Role of insulinemia in arterial disease. Acta Diabetol Lat 1971 0.75
218 Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake. Atherosclerosis 1986 0.75
219 Postheparin plasma lipoprotein and hepatic lipase activities in hyperinsulinemic infants of diabetic mothers and in large-for-date infants at birth. Pediatr Res 1986 0.75
220 [LDL apheresis--an effective treatment of homozygous familial hypercholesterolemia]. Duodecim 1990 0.75
221 Accelerated turnover of very low density lipoprotein triglycerides in chronic alcohol users. A possible mechanism for the up-regulation of high density lipoprotein by ethanol. Atherosclerosis 1984 0.75
222 The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD. Perit Dial Int 1999 0.75
223 Different effects of continuous oestrogen-progestin and transdermal oestrogen with cyclic progestin regimens on low-density lipoprotein subclasses. Eur J Clin Invest 1996 0.75
224 Seventy years of insulin: where are we now? Ann Med 1992 0.75
225 [Prevention of dyslipidemia--the foremost challenge in the management of diabetes]. Lakartidningen 1999 0.75
226 [Hemoglobin A1c in the evaluation of diabetes]. Duodecim 1978 0.75
227 [Parenteral nutrition]. Duodecim 1983 0.75
228 The 17th annual meeting of the European Lipoprotein Club. Arterioscler Thromb Vasc Biol 1995 0.75
229 Postprandial responses of plasma lipids and lipoproteins in subjects with apoA-I(Lys107-->0). Atherosclerosis 1998 0.75
230 A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127. Biochim Biophys Acta 1992 0.75
231 [Insulinoma--diagnostic aspects]. Duodecim 1974 0.75
232 Lack of behavioural effects following intraventricular infusion of somatostatin in the conscious goat. Pharmacol Biochem Behav 1978 0.75
233 [Effect of pregnancy and oral contraceptives on glucose and insulin metabolism]. Duodecim 1969 0.75
234 One-year response to evening insulin therapy in non-insulin-dependent diabetes. J Intern Med 1992 0.75
235 Genetic variation in the amino-terminal part of apolipoprotein B: studies in hyperlipidemic patients. Atherosclerosis 1998 0.75
236 Effects of dietary carbohydrates in metabolic disturbances in man. Prog Biochem Pharmacol 1986 0.75
237 No evidence of amyloidosis in type I diabetics treated with continuous subcutaneous insulin infusion. Diabetes 1983 0.75
238 Lipid metabolism: new approaches to old problems. Curr Opin Lipidol 1998 0.75
239 Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly. Int J Obes 1977 0.75
240 Effects of interferon alpha on insulin binding and glucose transport in human adipocytes. Eur J Clin Invest 1992 0.75
241 The 13th annual meeting of the European Lipoprotein Club. Arterioscler Thromb 1991 0.75
242 [Clinico-pathological conference. Neuropsychiatric syndrome associated with cardiac, pulmonary and renal symptoms]. Duodecim 1976 0.75
243 Mutations affecting human lipoprotein lipase gene. Z Gastroenterol 1996 0.75
244 [Familial combined hyperlipidemia; solution on the horizon?]. Duodecim 1995 0.75
245 Postmenopausal hormone replacement therapy and plasma lipoproteins. J Intern Med 1995 0.75
246 Effect of parenteral nutrition on the blood levels of insulin, glucagon, growth hormone, thyroid hormones and cortisol in catabolic patients. Acta Chir Scand 1982 0.75
247 Elevated adipose tissue lipoprotein lipase activity in craniopharyngioma patients. Metabolism 1988 0.75
248 Pathology of renal arteries of dyslipidemic children with congenital nephrosis. APMIS 1994 0.75
249 [Program for the prevention and therapy of diabetes]. Duodecim 2000 0.75
250 Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis. Clin Nephrol 1994 0.75
251 [Diabetic ketotic coma]. Duodecim 1973 0.75
252 Effect of acute ethanol load on postheparin plasma lipoprotein lipase and hepatic lipase activities and intravenous fat tolerance. Horm Metab Res 1978 0.75
253 [Hypoglycemia]. Duodecim 1974 0.75
254 Development and evaluation of an ELISA method for the determination of lipoprotein lipase mass concentration--comparison with a commercial, one-step enzyme immunoassay. Eur J Clin Chem Clin Biochem 1996 0.75